aap Implantate AG/€AAQ1
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About aap Implantate AG
aap Implantate AG is a medical technology company based in Berlin, Germany, specializing in the development, production, and marketing of trauma products. Its portfolio includes the LOQTEQ® anatomical plating system and a range of cannulated screws. The company is also advancing technologies such as antibacterial silver coating and magnesium-based implants to address unmet needs in trauma care. In Germany, aap sells directly to hospitals and purchasing groups, while internationally, it operates through distributors in approximately 25 countries. In the United States, sales are managed via its subsidiary, aap Implants Inc., utilizing both distribution agents and partnerships with orthopedic companies. In 2023, aap established a research and development and production headquarters in Suzhou, China, to conduct clinical trials on high-end silver ion anti-infection implants. ([govt.chinadaily.com.cn](https://govt.chinadaily.com.cn/s/202303/17/WS6416c3e8498ea274927b2869/aap-implantate-ag-to-open-headquarters-in-snd.html?utm_source=openai))
Ticker
€AAQ1
Sector
Primary listing
XETRA
Industry
Health Care Equipment & Supplies
Headquarters
Employees
87
ISIN
DE000A3H2101
Website
AAQ1 Metrics
BasicAdvanced
€24M
-
-€0.46
0.06
-
Price and volume
Market cap
€24M
Beta
0.06
52-week high
€1.70
52-week low
€1.08
Financial strength
Current ratio
2.123
Quick ratio
0.745
Long term debt to equity
18.707
Total debt to equity
27.017
Interest coverage (TTM)
-21.04%
Profitability
EBITDA (TTM)
-1.709
Gross margin (TTM)
76.82%
Net profit margin (TTM)
-32.92%
Operating margin (TTM)
-20.16%
Effective tax rate (TTM)
2.07%
Revenue per employee (TTM)
€140,000
Management effectiveness
Return on assets (TTM)
-7.61%
Return on equity (TTM)
-30.29%
Valuation
Price to revenue (TTM)
1.231
Price to book
1.4
Price to tangible book (TTM)
1.4
Price to free cash flow (TTM)
-5.467
Free cash flow yield (TTM)
-18.29%
Free cash flow per share (TTM)
-31.46%
Growth
Revenue change (TTM)
2.13%
Earnings per share change (TTM)
48.42%
3-year revenue growth (CAGR)
1.68%
10-year revenue growth (CAGR)
-8.87%
3-year earnings per share growth (CAGR)
-27.98%
10-year earnings per share growth (CAGR)
-9.32%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for aap Implantate AG stock?
aap Implantate AG (AAQ1) has a market cap of €24M as of July 03, 2025.
What is the P/E ratio for aap Implantate AG stock?
The price to earnings (P/E) ratio for aap Implantate AG (AAQ1) stock is 0 as of July 03, 2025.
Does aap Implantate AG stock pay dividends?
No, aap Implantate AG (AAQ1) stock does not pay dividends to its shareholders as of July 03, 2025.
When is the next aap Implantate AG dividend payment date?
aap Implantate AG (AAQ1) stock does not pay dividends to its shareholders.
What is the beta indicator for aap Implantate AG?
aap Implantate AG (AAQ1) has a beta rating of 0.06. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.